/ CompletedNot Applicable Assessing the Effect of the MYODM Food Supplement on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1
The purpose of this study is to determine whether MYODM (formulated composition containing Theobroma cacao supplemented with caffeine (caffeine/theobromine ratio1/1.85, w/w) is effective in the treatment of excessive daytime sleepiness due to myotonic dystrophy type 1 (DM1) and improves the quality of life of these patients.
100 Clinical Results associated with Myogem Health Co. SL
0 Patents (Medical) associated with Myogem Health Co. SL
100 Deals associated with Myogem Health Co. SL
100 Translational Medicine associated with Myogem Health Co. SL